Welcome to our Evotec Blog.

Hope you will find our articles and resources relevant for your projects and interests.

Our experts are available for any additional information and to assist with your project challenges!

Just contact us.

 

 

2018

Evotec publishes DDup 7 – Kidney diseases 2.0
Nerina Coppini, 28 September 2018

In this 7th DDup issue, we delve into the unique new kidney platforms poised to change the trajectory of kidney disease research and therapeutics development. Evotec has embarked on a novel collaboration model with Kidney Research UK, University of Bristol, University of Cambridge, University of Nottingham and the Mario Negri Institute in...

Evotec and Almirall enter into research collaboration in the field of dermatological diseases
Nerina Coppini, 17 September 2018

Collaboration is focused on first-in-class therapies to treat dermatological diseases Collaboration leverages a novel approach to disrupt cell signalling, validated by EVT Innovate

Evotec AG listed in MDAX
Nerina Coppini, 6 September 2018

Dual-listing of Evotec AG share in TecDAX and MDAX as of 24 September 2018 

Evotec and Celgene enter partnership in the field of targeted protein degradation
Nerina Coppini, 6 September 2018

The collaboration will focus on targeted protein degradation Evotec's panomics and data analytics platforms will be leveraged Financials include upfront payment as well as significant potential milestone-based payments and royalties

Yumanity Therapeutics announces first clinical candidate for the potential treatment of Parkinson’s disease
Nerina Coppini, 5 September 2018

First-in-Human Trials Planned for the Fourth Quarter of 2019 IND-Enabling Studies to Be Completed Utilizing Evotec INDiGO Platform

 

 

Contact us

Evotec

Business Development

T +44.(0)1235.86 15 61 T +1.732 329 2355 x3308